BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 14572341)

  • 1. [Detection and analysis of the new kind of G743C and G743A point mutation of HBV P gene in hepatitis B virus infected patients resistant to lamivudine].
    Pan XP; Wo JE; Chen Z; Chen F; Liang WF; Liu KZ
    Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):616-8. PubMed ID: 14572341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Types and emergence time of YMDD motif mutation in hepatitis B virus polymerase gene during lamivudine treatment].
    Liang WF; Yang DH; Shen YH; Xie YJ; Zhao NF
    Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):302-4. PubMed ID: 12773248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of rare polymerase variants of hepatitis B virus using a two-stage PCR with peptide nucleic acid clamping.
    Ohishi W; Shirakawa H; Kawakami Y; Kimura S; Kamiyasu M; Tazuma S; Nakanishi T; Chayama K
    J Med Virol; 2004 Apr; 72(4):558-65. PubMed ID: 14981758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel accurate ACRS-PCR method with a digestion internal control for identification of wild type and YMDD mutants of hepatitis B virus strains.
    Hosseini SY; Sabahi F; Amini-Bavil-Olyaee S; Alavian SM; Merat S
    J Virol Methods; 2006 Nov; 137(2):298-303. PubMed ID: 16962669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study on detection method of lamivudine related mutations in hepatitis B virus polymerase gene].
    Ding JJ; Zhang WS; Zhang LS
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Mar; 18(1):24-7. PubMed ID: 15340520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PCR restriction fragment length polymorphism in detection of YMDD variants of viral polymerase in hepatitis B virus patients treated with lamivudine.
    Yang DH; Liang WF; Xie YJ; Zhao NF; Fan J
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):232-7. PubMed ID: 14612274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C.
    Pan XP; Li LJ; Du WB; Li MW; Cao HC; Sheng JF
    J Viral Hepat; 2007 Nov; 14(11):767-74. PubMed ID: 17927612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic changes of hepatitis B virus polymerase gene including YMDD motif in lamivudine-treated patients with chronic hepatitis B.
    Feng B; Wei L; Chen M; Wang L
    Microbiol Res; 2008; 163(4):487-92. PubMed ID: 17317127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy changes of short-term lamivudine therapy for chronic hepatitis B with emergence of YMDD mutation].
    Deng H; Lv Y; Fu J
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):368-9. PubMed ID: 15225437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences.
    Enomoto M; Tamori A; Kohmoto MT; Morikawa H; Habu D; Sakaguchi H; Takeda T; Seki S; Kawada N; Shiomi S; Nishiguchi S
    J Med Virol; 2007 Nov; 79(11):1664-70. PubMed ID: 17854034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of different methods in monitoring YMDD motif mutations associated with lamivudine resistance].
    Hu YY; Jiang JJ; Li D; Lin CW; Li QG; Chen Y
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jul; 11(7):427-30. PubMed ID: 12890350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YMDD mutants in patients with chronic hepatitis B before treatment are not selected by lamivudine.
    Matsuda M; Suzuki F; Suzuki Y; Tsubota A; Akuta N; Hosaka T; Someya T; Kobayashi M; Saitoh S; Arase Y; Satoh J; Kobayashi M; Ikeda K; Miyakawa Y; Kumada H
    J Med Virol; 2004 Oct; 74(2):361-6. PubMed ID: 15332287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection and identification of emergence of HBV YMDD motif mutation during lamivudine treatment by hybridization to an oligonucleotide array].
    Zhao W; Liu W; Liu QJ; Zhang L; Zhang HR; Liu XJ; Zhou ZX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Dec; 17(4):339-43. PubMed ID: 15340547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Natural YMDD motif mutations of HBV polymerase in the chronic hepatitis B virus infected patients].
    Shin YM; Heo J; Kim GH; Kang DH; Song GA; Cho M; Yang US; Kim CM; Park HK; Jang HJ
    Taehan Kan Hakhoe Chi; 2003 Mar; 9(1):1-9. PubMed ID: 12657823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High-flux detection of HBV lamivudine resistant strains by genechip and analysis of mutant hotspots in those strains].
    Li B; Zhou BP; Peng JF; Chen LY; Li LX; Wang ZQ; Wang M; Liu SY; Jiang XL
    Zhonghua Gan Zang Bing Za Zhi; 2004 Nov; 12(11):673-6. PubMed ID: 15623377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of mass spectrometric analysis and TRUGENE HBV genotyping for monitoring lamivudine resistance in chronic hepatitis B patients.
    Woo HY; Park H; Kim BI; Jeon WK; Cho YK; Kim YJ
    Antivir Ther; 2007; 12(1):7-13. PubMed ID: 17503742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus (HBV) genotype and YMDD motif mutation profile among patients infected with HBV and untreated with lamivudine.
    Amini-Bavil-Olyaee S; Hosseini SY; Sabahi F; Alavian SM
    Int J Infect Dis; 2008 Jan; 12(1):83-7. PubMed ID: 17698384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and profile of mutations associated with lamivudine therapy in Indian patients with chronic hepatitis B in the surface and polymerase genes of hepatitis B virus.
    Wakil SM; Kazim SN; Khan LA; Raisuddin S; Parvez MK; Guptan RC; Thakur V; Hasnain SE; Sarin SK
    J Med Virol; 2002 Nov; 68(3):311-8. PubMed ID: 12226816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Identification of factors associated with YMDD mutation in patients with chronic hepatitis B receiving lamivudine treatment].
    Cao XX; Li J; Qiu LM; Luo YW; Chen YH; Ran Y
    Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):641-4. PubMed ID: 19785947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of the mutation in HBV polymerase gene by RFLP PCR method in hepatitis B patients treated with lamivudine].
    Li Z; Guo YB; Hao W; Lin ZH; Jin HY; Liu DG
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):266-9. PubMed ID: 15340574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.